U=U can help end HIV stigma and discrimination. Here’s how
U=U is short for Undetectable = Untransmittable. It means that when a person living with HIV, adheres to effective antiretroviral treatment, the virus in their blood reduces to a level that is undectable, bringing the chance of passing the virus on to zero.
Bold new initiative to put an additional 1.1 million people living with HIV on treatment puts South Africa on the path to end AIDS as a public health threat by 2030
JOHANNESBURG/GENEVA, 25 February 2025—UNAIDS welcomes South Africa’s plan to put an additional 1.1 million people living with HIV on life-saving treatment by the end of 2025 as a significant step towards ending AIDS as a public health threat by 2030. At the launch of the Close The Gap campaign in Soweto South Africa’s Minister of Health, Aaron Motsoaledi, said, “We should not accept that AIDS is here forever. It is not. We want to end it. It’s all in our hands and it depends on our will. We can…
A crisis unfolding: hard-won progress in Ethiopia’s HIV response at risk
Ethiopia has made significant progress in its HIV response in recent years and is on track to reach the UNAIDS 95-95-95 targets with 90% of people living with HIV in the country being aware of their HIV status; 94% of those diagnosed with HIV receiving antiretroviral (ARV) therapy; and 96% of people on ARV therapy achieving viral suppression. But now, that progress is at risk. The recent pause in United States foreign assistance poses a direct threat to the lives and well-being of thousands of…
UNAIDS welcomes the decision by the US Secretary of State to continue life-saving HIV treatment and convenes partners to assess and mitigate impacts on HIV services
The United States Secretary of State, Marco Rubio, has approved an “Emergency Humanitarian Waiver”, which will allow people to continue accessing HIV treatment funded by the US across 55 countries worldwide. More than 20 million people living with HIV, representing two-thirds of all people living with HIV receiving treatment globally, are directly supported by the United States President's Emergency Plan for AIDS Relief (PEPFAR) - the world’s leading HIV initiative.
Lost and link: Indonesian initiative to find people living with HIV who stopped their treatment
Grabbing his helmet, Hadi Timotius gets in the back of his colleague’s scooter to pay a routine visit to a woman who is taking her HIV treatment again. Hadi oversees the ‘Lost and Link’ initiative at JIP, a national network of people living with HIV in Indonesia.
Global leaders in the HIV response call for access to long-acting medicines
NAIROBI, 10 December 2024—Today, at the 55th Programme Coordinating Board for the Joint United Nations Programme on HIV/AIDS (UNAIDS), HIV leaders from across the world called for access to long-acting medicines for everyone who would benefit from them, to build toward a new era in the AIDS response.
Peru approves groundbreaking law to extend health coverage for migrants with HIV and TB
In a milestone decision, the Peruvian Congress has passed legislation that extends temporary health insurance coverage to migrants diagnosed with HIV and tuberculosis (TB). This law allows non-resident foreigners to access healthcare services through the public health insurance system (known by the Spanish acronym SIS) while they complete their immigration processes.
Can this innovation change the way people think about HIV?
In 2020, a gay Thai man living with HIV sparked controversy with a Facebook post. He was on antiretroviral therapy and had gotten lab tests to check the level of virus in his blood. Since his viral load was undetectable, he wrote, he was going to stop using condoms.
New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says
GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing medicine.”
United Nations General Assembly debate highlights the need for urgent action to ensure that progress in the HIV response is accelerated and sustained
On 19 June 2024, the United Nations General Assembly convened to evaluate the progress made in the response to the AIDS epidemic. The yearly session provided a platform for Member States to reflect on achievements, confront persistent barriers, and chart a course forward towards ending AIDS by 2030. The UN Secretary-General’s progress report formed the basis of the debate.
